ISSN
1751-4983 |
|
 |
Patricia
McDonnell, Publisher,
Oncology News,
McDonnell Mackie Publishing,
84 Camderry Road,
Dromore, Co Tyrone,
BT78 3AT, UK.
T: 0288 289 7023
E: info@oncologynews.biz |
|
 |
|
| |
|
 |
Prof Denys Wheatley,
Director of BioMedES, & an Experimental Oncologist/Cell
Biologist, Aberdeen.
Mr Patrick Bradley,
Otolaryngologist,
Head and Neck Surgeon,
Surgical Oncologist
University Hospital Nottingham.
Dr Richard J Ablin,
Research Professor of Immunobiology and
Pathology
University of Arizona College of Medicine |
|
 |
 |
| If
you would like to receive a regular FREE copy of Oncology
News, simply email your name, job title and address to
subscribers@oncologynews.biz |
|
 |
 |
Do
you have a topical article you would like to publish,
or would you like to review books, journals, websites
or conferences?
If you do, please contact enquiries@oncologynews.biz
or call +44 (0) 288 289 7023. |
|
|
|
 |
 |
| |
 |
 |
Professor
Denys Wheatley is Editor of Oncology News, and is Director
of BioMedES. In 1998, Denys became editor of Cell Biology
International, and its reemergence
and success led to a new online open access journal called
Cancer Cell International. Latterly (May 2004), he started
a second highly successful online open access journal called
Theoretical Biology and Medical Modelling. He has strong
research ties in Albany, Davis, Auckland, Valencia, Detroit,
Budapest, St Petersburg, Heidelberg, Zürich and Hong
Kong. He is eager to establish strong interaction with
cancer and cell biology teams worldwide, and initiate programmes
in the areas in which his expertise lies. His work in cancer
research, other scientific fields, with IFCB, and in publishing
and scientific communication has led to his receiving awards
in recent years from Budapest (Professor of the Semmelweis
Medical University), the Khwarizmi International Award
for Science (Islamic Republic of Iran), a silver ‘Hippocrates’ award
from the Medical University of Odessa (Ukraine), and a
visiting chair of physiology/cancer research at Wayne State
Medical School, Detroit, USA. |

|
 |
|
Mr Patrick
J Bradley is Associate Editor of Oncology News, and,
a Head and Neck Oncologic Surgeon at the University Hospital,
Nottingham. He completed his Otorhinolaryngology - Head
and Neck Surgery residency in Liverpool. He is a member
of numerous journals’ UK Editorial Boards; Journal
of Laryngology and Otology, Oral Oncology, and International
Journals: Laryngoscope, Head and Neck, Acta Otolaryngologica
Scandinavia, as well as Section Editor of Head and Neck
Oncology, and Current Opinions ORL-HNS. He has been the
Gene Myers International Head and Neck Lecturer at the
American Academy ORL-HNS in 2000. He recently completed
an MBA (Health) at Nottingham University through an NHS
Bursary over a five-year period. He is a member of the
RCS London, Cancer Committee representing BAOHNS, and is
Chairman of the BAOHNS Cancer Committee. He has been President
of the British Association of Head and Neck Oncologists
(2003 – 2005), and is currently President of the
European Laryngological Society (2004 – 2006). He
is a Founder Board Member of the European Head and Neck
Society. He is the National Lead Clinician – Head
and Neck Surgery for the English National Health Service
(2003 – 2006). |

|
 |
|
Dr Richard J Ablin (Associate Editor), is Research Professor of Immunobiology and
Pathology, University of Arizona College of Medicine and a Member of the Arizona Cancer
Center, Tucson, Arizona. He received the First Award for scientific excellence from The Haakon
Ragde Foundation for Advanced Cancer Studies. Dr Ablin discovered prostate-specific antigen
(PSA) in 1970. A pioneer of cryosurgery and cryoimmunotherapy, he has extensive
experience in cancer research. |

|
 |
|
Dr Tom
Lynch is Assistant Editor – Imaging, and
is a Radiologist and Lead Nuclear Medicine Physician in
the Northern Ireland Cancer Centre based at the Belfast
City Hospital. Tom specialises in PET/CT scanning and nuclear
medicine with a special interest in paediatric nuclear
medicine. He also has an interest in radionuclide therapy,
which is a rapidly developing area of interest in oncology
using targeted therapy with beta emitters. Tom has a long
history of involvement with undergraduate teaching and
lectures regularly on PET/CT and Radionuclide therapy. |

|
 |
|
Dr Heidi
Sowter is Assistant Editor – Web Review,
and is a Lecturer in Forensic Science and Biology, at the
Faculty of Education, Health and Science, University of
Derby. Heidi became interested in oncology whilst working
for a biotechnology company to automate cervical screening
using labelled monoclonal antibodies raised from various
cells along the CIN pathway. This interest took her to
the Cambridge University Department of Obstetrics and Gynaecology
at Addenbrookes Hospital, where she completed a PhD on
Angiogenic Factors in Ovarian Cancer. Heidi continues to
pursue her research interests in gynaecological and breast
cancer. |

|
 |
|
Ms Kathleen
Mais is Assistant Editor – Nursing,
and is a Nurse Clinician in Head & Neck Oncology at
Christie Hospital, Manchester. Kathleen qualified as a
nurse in Newcastle-upon-Tyne. She worked as a ward sister
on a female head and neck/ENT surgery ward, then as a sister
in the Radiotherapy Outpatient Department at the Royal
London Hospital. After completing a second Master’s
degree in Clinical Nursing she took up her current position
of Nurse Clinician. Kathleen is a nurseprescriber and runs
a nurse-led chemotherapy clinic as well as continuing her
work in clinical research. |

|
 |
|
Dr S Gokul
is Assistant Editor - Journal Reviews, and
is a Consultant Medical Oncologist at The James Cook University
Hospital, Middlesbrough, he undertook his oncology training
at Newcastle upon-Tyne. His areas of interest are lung
and gynaecological cancers. |

|
 |
|
Helen
Evans is a Journal Reviewer for Oncology News and
works as a Senior Lecturer in Cancer Nursing at the Institute
of Nursing and Midwifery, University of Brighton. Helen’s
career in cancer nursing started on qualifying in 1987
and has spanned a range of roles from staff nurse to oncology
service manager. |

|
 |
|
Marilena Loizidou
is Assistant Editor – Colorectal, and
is a nonclinical senior lecturer in the Department of Surgery,
UCL. Previously, she held a research scientist post in
the Department of Surgery, Southampton General Hospital.
Marilena graduated in Biochemistry (Canada) and Pharmacology
(Southampton) and completed a PhD in the biology of solid
tumours (Southampton). Her research program focuses on
aspects of colorectal cancer and liver metastases, from
the basic underlying biology to new potential treatments
and she has published extensively in the field. The current
focus of research is the contribution of
the peptide endothelin-1 to tumour growth and
progression in the bowel. Additional research areas include
breast and bladder cancer. Marilena has contributed to
the
design of an intercalated BSc and a Surgical MSc at UCL
and lectures regularly. |

|
 |
|
Alan
Cooper is Assistant Editor – Urology,
and is lead scientist with the urology research group
in Southampton University Hospitals and senior lecturer
(albeit with virtually no lecturing burden) in the Department
of Biomedical Sciences at Portsmouth University. His
university education was in departments of zoology and
immunology, but since joining the Southampton University
Department of Surgery in 1974 has increasingly serviced
the research interests of the Wessex urological fraternity,
working for them exclusively over the last twelve years.
His particular interest is live-cell imaging, exploited
most extensively in the context of multidrug resistance
in bladder cancer. |

|
 |
|
Michael
Douek is Assistant Editor – Breast,
and is a Senior Lecturer and Consultant Surgeon at University
College London Hospitals focusing on breast cancer surgery
(including intra-operative radio - therapy, sentinel node
biopsy and reconstruction) with a particular interest in
pre-operative surgical planning using breast MRI. His translational
research program evaluates novel imaging modalities to
improve breast conserving surgery for cancer. He is a regular
speaker at national and international conferences, published
several papers in this area and made contributions in the
health media. Michael graduated from the University of
Dundee (Scotland) and trained in surgery in London, Oxford
and Cambridge. He obtained his MD from the University of
London in 2000. In 2003, he was awarded a prestigious Health
Foundation Clinician Scientist grant by the UK Academy
of Medical Sciences, fully funding his joint academic and
clinical post in breast surgery. |
|
| |
|
| |
|
| |
|
|
|